Results 211 to 220 of about 364,936 (336)

Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs

open access: hybrid, 2021
Ke Pan   +9 more
openalex   +1 more source

Platelet Rubicon Bidirectional Regulation of GPVI and Integrin αIIbβ3 Signaling Mitigates Stroke Infarction Without Compromising Hemostasis

open access: yesAdvanced Science, EarlyView.
This study identifies Rubicon as a key platelet protein that bidirectionally regulates GPVI and integrin αIIbβ3 signaling. Platelet Rubicon protects against cerebral ischemia‐reperfusion injury by limiting infarction without increasing hemorrhage.
Xiaoyan Chen   +11 more
wiley   +1 more source

Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18(+) Escherichia coli infection [PDF]

open access: yes, 2007
CLEMENTSD, J   +6 more
core   +1 more source

Regulating Tumor Metabolic Reprogramming with Biomimetic Co‐Delivery of Simvastatin and Kynureninase for Immunotherapy

open access: yesAdvanced Science, EarlyView.
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin   +6 more
wiley   +1 more source

Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.

open access: green, 1985
Gregory Milman   +8 more
openalex   +2 more sources

Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity [PDF]

open access: bronze, 2017
Regina Salvat   +6 more
openalex   +1 more source

Three‐Year Follow‐Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer‐Associated Fibroblast Heterogeneity Corresponding to PD‐1 Blockade Efficacy

open access: yesAdvanced Science, EarlyView.
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin   +14 more
wiley   +1 more source

Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors [PDF]

open access: bronze, 2015
Ronit Mazor   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy